This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ijdo, J. W.
Right arrow Articles by Fikrig, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ijdo, J. W.
Right arrow Articles by Fikrig, E.

 Previous Article  |  Next Article 

Infect Immun, July 1998, p. 3264-3269, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Cloning of the Gene Encoding the 44-Kilodalton Antigen of the Agent of Human Granulocytic Ehrlichiosis and Characterization of the Humoral Response

Jacob W. Ijdo,1 Wei Sun,1 Yan Zhang,1 Louis A. Magnarelli,2 and Erol Fikrig1,*

Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8031,1 and The Connecticut Agricultural Experiment Station, New Haven, Connecticut 065042

Received 12 February 1998/Returned for modification 24 March 1998/Accepted 10 April 1998

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Antibodies in the sera of patients with human granulocytic ehrlichiosis (HGE) commonly recognize a 44-kDa antigen. We cloned the gene encoding the 44-kDa protein of the agent of HGE (aoHGE) by probing an aoHGE lambda ZAP II genomic DNA expression library with sera from aoHGE-infected mice. The gene, hge-44, is part of a multigene family, with sequence similarity to the Anaplasma marginale msp-2 genes. RNA-PCR studies confirmed that hge-44 is expressed by aoHGE cultured in HL-60 cells and by aoHGE during murine infection. Recombinant HGE-44, expressed and purified as a glutathione transferase fusion protein, was used as the substrate in immunoblots to help diagnose HGE. Antibodies in eight sera from eight patients with HGE and in two sera from two aoHGE-infected mice bound recombinant HGE-44. Antibodies in the sera of healthy individuals or patients with Ehrlichia chaffeensis or Borrelia burgdorferi infection did not recognize HGE-44. We conclude that hge-44 is a member of a multigene family and that hge-44 is expressed and elicits specific antibodies during infection.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Human granulocytic ehrlichiosis (HGE) is a recently recognized tick-borne infectious disease in the United States and Europe (4, 5, 10, 24, 26). Ixodes scapularis is a vector of the agent of HGE (aoHGE) (21), an organism that is closely related to Ehrlichia equi and Ehrlichia phagocytophila (6). Clinical infection produces acute symptoms including fever, leukopenia, thrombocytopenia, and myalgias; severe secondary complications can occasionally result in death (1, 13). Diagnosis may be aided by the identification of the characteristic aoHGE morulae in neutrophils in a peripheral blood smear (4) or by DNA detection methods such as PCR (6). Serologic tests such as immunofluorescence (IFA) (1, 17, 18) and immunoblotting with E. equi-infected equine neutrophils or aoHGE cultured in HL-60 cells have also proven helpful for diagnosis (15, 28).

The aoHGE 44-kDa protein is commonly recognized by immunoglobulin M (IgM) and IgG antibodies in the sera of patients with HGE (8, 15, 19, 28). Examination of aoHGE isolated from different patients reveals that although this antigen usually migrates at about 44 kDa, the molecular size may vary from 42 to 49 kDa, suggesting molecular structural differences which may account for the observed antigenic diversity (3, 30). Fractionation studies indicate that the 44-kDa protein may be located in the aoHGE outer membrane (30). It has recently been shown that sera from mice immunized with aoHGE lysates are sufficient to partially protect mice from aoHGE infection (25). This murine aoHGE antiserum has high concentrations of antibodies that bind the 44-kDa protein, suggesting that 44-kDa-protein-specific antibodies may play a role in immunity against infection. This immunogenic antigen may therefore be important in pathogenesis and laboratory diagnosis and serve as a candidate for an HGE vaccine. The gene encoding the aoHGE 44-kDa antigen has now been cloned, and the humoral response to the recombinant protein has been characterized.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Isolation of HGE organisms. The promyelocytic cell line HL-60 (ATTC CCL 240) was cultured in Iscove's modified Dulbecco's medium supplemented with 20% fetal bovine serum and was maintained at 37°C with 5% carbon dioxide (11). HL-60 cells were infected with the NCH-1 strain of aoHGE and cultured (15). The cell density was maintained at between 5 × 105 and 1.5 × 106 cells per ml by feeding the cells twice a week. If the cell count was below 5 × 105 cells per ml, fresh HL-60 cells were added to a final concentration of 1 × 106 cells per ml. Light microscopy slides of cultured HL-60 cells were air dried, stained with Diff-Quik (Baxter Healthcare Corp., Miami, Fla.), and examined for aoHGE infection.

Large volumes of infected HL-60 cells were grown for purification of bacteria by Renografin density gradient centrifugation as described previously (7, 12) with some modifications. Briefly, cultures with at least 70% aoHGE-infected HL-60 cells were centrifuged and resuspended in phosphate-buffered saline (PBS)-0.1% glucose. HL-60 cells were lysed by shearing with a 21-gauge needle, and the cellular debris was pelleted by centrifugation at 1,500 × g (Sorvall RT600B; Sorvall, Newtown, Conn.) for 10 min. The supernatant was collected and incubated with RNase and DNase (Boehringer, Mannheim, Germany) (final concentration, 50 µg/ml). By using Renografin with a noncontinuous gradient of 42 and 30% (Hypaque 76; Nycomed Inc., New York, N.Y.), ultracentrifugation was performed at 87,000 × g for 75 min at 4°C in an SW-28 swing bucket rotor (Beckman, Fullerton, Calif.). The interface band was collected in a sterile pipette, dissolved in SPGN (7.5% sucrose, 3.7 mM KH2PO4, 7 mM K2HPO4 and 5 mM L-glutamine), and pelleted at 12,000 × g (Sorvall rotor SS-34), and the HGE bacteria were resuspended in SPGN at a concentration of 2 µg/µl and stored at -70°C.

HGE library construction, screening, and sequencing. For construction of the lambda ZAP II aoHGE genomic DNA expression library, purified aoHGE was used to extract DNA as described previously (22). After random shearing of 100 µg of aoHGE DNA, EcoRI adapters were ligated to the ends and subsequently size fractionated (from 1 to 9 kb), and DNA was inserted into the lambda ZAP II vector (Stratagene, La Jolla, Calif.). The lambda ZAP II phages were plated on a lawn of Escherichia coli XL-1 Blue (Stratagene), and protein expression was induced with 10 mM isopropyl-beta -D-thiogalactoside (IPTG).

In order to identify immunogenic aoHGE proteins, nitrocellulose filters containing the expressed proteins were incubated with hyperimmune murine antiserum (1:1,000 dilution). Hyperimmune antiserum was produced by immunizing 10 C3H/HeJ mice with a lysate of purified aoHGE in complete Freund's adjuvant and boosting the animals twice with the same preparation in incomplete Freund's adjuvant at 2-week intervals. This serum has been shown to contain high concentrations of antibodies that bind the 44-kDa antigen in aoHGE lysates (25). After being washed, the nitrocellulose filters were incubated with a 1:5,000 dilution of alkaline phosphatase-conjugated goat anti-mouse IgG antibody (Sigma, St. Louis, Mo.), washed again, and then immersed in 5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium (BCIP-NBT) (KPL, Gaithersburg, Md.) for color visualization.

After secondary screening, reactive clones were subjected to in vivo excision by simultaneous infection of E. coli XL-1 Blue cells with R408 helper phage (Stratagene), resulting in replication and recircularization of a single-stranded DNA molecule of the cloned insert and the pBluescript vector. This single-stranded plasmid was then packaged, secreted, and made double stranded by reinfection with fresh E. coli XL-1 Blue cells. Plasmid DNA was purified and sequenced by using the T3 and T7 primers and additional internal primers at approximate distances of 250 bp, so that both strands of the clone were sequenced entirely.

Partial internal protein sequencing. aoHGE bacteria, purified from infected HL-60 cultures, were lysed, dissolved in sample buffer (5% 2-mercaptoethanol, 10% glycerol, 2% sodium dodecyl sulfate [SDS], and 0.8% bromophenol blue in 6.25 mM Tris buffer, pH 6.8), and heated for 10 min at 100°C. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed with 20 µg of aoHGE protein. The 44-kDa band was excised from the gel and used for peptide sequencing at the Yale Protein Purification and Analysis Facility. Because amino-terminal sequencing was not successful, the protein was subjected to in-gel trypsin digestion, and two aliquots were selected for sequencing by matrix-assisted laser desorption-ionization mass spectrometry, yielding two peptide sequences from the 44-kDa protein.

Protein expression and purification. By using 5'-AAACCCGAATTCATGTCTATGGCTATAGTCATGGCTGGG-3' and 5'-ATATATCTCGAGTCATTAAAAAGCAAACCTAACACC-3' primers, a PCR-derived subclone of EM3C (a phage clone that contained the hge-44 gene [see Results]) containing the full-length gene sequence was then constructed in frame with the glutathione S-transferase (GT) gene by using the pMX vector (23). This clone, designated hge-44-pMX, was used to transform E. coli XL-1 Blue. After lysis of the cells and pelleting of the cell membranes, the soluble fraction (supernatant) and the cell pellet were subjected to SDS-PAGE and stained with Coomassie blue. Part of the GT-HGE-44 fusion protein appeared to be in the soluble fraction. GT-HGE-44 was then purified from the whole-cell lysate by using a glutathione-Sepharose-4B column.

PCR and RNA-PCR. Total aoHGE RNA, isolated from cultured and purified aoHGE, was used as a template for PCR to verify the presence and expression of hge-44. The primers used for PCR and RNA-PCR were 5'-AGCGTAATGATGTCTATGGC-3', starting at position 43, and 5'-ACCCTAACACCAAATTCCC-3', starting at position 1322. The denaturing, annealing, and extension temperatures were 94, 58, and 72°C, respectively, for 1 min at each step for 30 cycles, yielding an expected product of 1,279 bp. For RNA-PCR, total RNA was isolated from cultured HGE bacteria and from spleens of experimentally infected mice, by using a Micro RNA isolation kit (Stratagene). First-strand cDNA was synthesized with random primers from 5 µg of total aoHGE RNA and splenic RNA. Control studies were performed without reverse transcriptase to eliminate the possibility of DNA contamination.

Southern blotting. DNA of aoHGE (5 µg per lane) was digested with restriction enzymes BamHI, BglII, KpnI, and PstI, electrophoresed, blotted onto nylon membranes (Hybond; Amersham, Arlington Heights, Ill.), and probed with insert of EM3C. The probe was labeled by use of a nonradioactive chemiluminescence kit (ECL; Amersham). After hybridization, blots were washed with 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 1× SSC, and 0.5× SSC for 15 min each and then exposed to X-ray film (Kodak, Rochester, N.Y.) for 24 h.

Immunoblotting. SDS-PAGE separation of recombinant protein was performed by using 10% acrylamide gels under reducing conditions (22). Two micrograms of GT-HGE-44 or GT (control) dissolved in sample buffer (5% 2-mercaptoethanol, 10% glycerol, 2% SDS, and 0.8% bromophenol blue in 6.25 mM Tris buffer, pH 6.8) and heated for 10 min at 100°C was loaded onto each lane of the gel. Molecular mass standards (Bio-Rad Laboratories, Hercules, Calif.) were used for each panel. Protein was transferred to nitrocellulose, and the blocking procedure was performed with PBS-5% nonfat dry milk. The antigen was incubated with a 1:100 dilution of human or murine serum, washed three times with PBS-0.2% Tween, and then incubated with the secondary conjugated antibody and washed three times in PBS-0.2% Tween. The second antibody, alkaline phosphatase-conjugated F(ab')2 anti-human or anti-mouse IgM or IgG (Sigma), was used as specified by the manufacturer.

Human and murine sera. Previously characterized sera from persons with HGE were used (15). All of the patients lived in areas where HGE was endemic and had clinical signs and symptoms which were compatible with HGE, including fever, leukopenia, or thrombocytopenia and myalgias. All patients had morulae in peripheral neutrophils and/or had serum antibodies to aoHGE, as detected by IFA. The IFA test was independently performed at the State of Connecticut Agricultural Experiment Station Reference Laboratory (18). Moreover, subjects had antibodies to aoHGE that were readily detected in immunoblots with aoHGE lysates as the substrate (15). In addition, sera from healthy individuals, patients with Ehrlichia chaffeensis infection, and persons who had Lyme borreliosis were kindly provided by J. G. Olson, Centers for Disease Control and Prevention, Atlanta, Ga., by the Connecticut State Health Department, and by the clinical diagnostic laboratory of the Section of Rheumatology, Yale University School of Medicine. Sera were also available from earlier studies on aoHGE-infected or naive (control) mice (25).

Nucleotide sequence accession number. The nucleotide sequence has been submitted to GenBank (accession no. AF037599).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Cloning of the hge-44 gene. aoHGE was subjected to SDS-PAGE, and the 44-kDa antigen was identified on a Coomassie blue-stained gel and excised. Amino-terminal peptide sequencing did not yield any sequence; therefore, internal protein sequencing was attempted. The 44-kDa antigen was digested with trypsin, and two peptides were subjected to sequence analysis. The identified peptide sequences were Val-Glu-Leu-Glu-Ile-Gly-Tyr-Glu-Arg and Val-Val-Gly-Asp-Gly-Asp-Tyr-Asp-Asp-Leu-Pro, and both had similarity with the protein sequences of the major surface protein encoded by msp-2 of Anaplasma marginale (9), a related organism that causes bovine anaplasmosis (20).

A lambda ZAP II aoHGE genomic DNA expression library was then constructed to identify phage clones that expressed immunoreactive antigens, specifically focusing on the 44-kDa protein. Primary and secondary screening of 5,000 colonies by using hyperimmune murine sera identified three phage plaques that expressed proteins that bound aoHGE antibodies. One clone, designated EM3, contained a partial open reading frame (ORF) with similarity to the A. marginale msp-2 gene family.

One of the two protein sequences obtained from the aoHGE 44-kDa protein was contained in the predicted amino acid sequence of the coding sequence of EM3. The 5' sequence of the EM3 ORF was not present in the insert, and we postulated that the second 44-kDa peptide sequence was contained within this region. The library was then probed with a 217-bp sequence generated by PCR (from nucleotide 390 to 607) (Fig. 1), yielding 20 positive plaques from 5,000 plaques. Eight clones were then randomly picked for further analysis. One clone, designated EM3C, contained potentially a full-length ORF and the predicted amino acid sequence containing both of the peptides that were identified from the 44-kDa aoHGE protein (Fig. 1). This aoHGE gene was designated hge-44, and the deduced amino acid sequence had substantial similarity (62% similarity and 53% identity) with the A. marginale msp-2 product, especially at the 3' half of the sequence (Fig. 2). A short stretch at the amino terminus has much lower similarity and is not shown in Fig. 2. Hydrophobicity analysis suggests that there is at least one possible membrane-spanning domain between amino acids 335 and 358. The amino terminus contains a putative start codon and a hydrophobic core of 16 amino acids, as predicted by the Kyte-Doolittle plot obtained by using the Macvector program (Oxford Molecular Group Inc., Campbell, Calif.), followed by the putative cleavage site at six amino acids from the end of the hydrophobic core.


View larger version (50K):
[in this window]
[in a new window]
  		FIG. 1.   Nucleotide sequence of hge-44 (from clone EM3C) and the deduced protein sequence. The putative cleavage site is indicated by a triangle. Underlined are the two peptide sequences that were obtained from the native aoHGE 44-kDa antigen and show a perfect match with the predicted amino acid sequence. The stop codon is indicated by an asterisk.


View larger version (68K):
[in this window]
[in a new window]
  		FIG. 2.   Bestfit alignment of HGE-44 (top row) and MSP-2 (bottom row) protein sequences. Identical amino acids are indicated by a vertical line. Conservative substitutions are indicated by one dot where the residue comparison values are >= 0.1 and by two dots where the residue comparison values are >= 0.5. ... . . denotes a gap used to better align the sequences.

Some of the other clones contained only partial ORFs, which were found to have substantial similarity with sequence at the 3' end of hge-44 but differed significantly in other areas, as shown in Fig. 3. A Southern blot hybridization was then performed, by using the restriction enzymes BamHI, BglII, KpnI, and PstI, which do not have restriction sites within the full-length EM3C ORF. An hge-44 probe, generated by PCR with EM3C as a template, would therefore be expected to reveal one hybridizing band if hge-44 is a single-copy gene. However, Southern blot hybridization revealed multiple bands, suggesting that there are several sequences that hybridize with EM3C (not shown).


View larger version (14K):
[in this window]
[in a new window]
  		FIG. 3.   Schematic map of clones that have similarity with hge-44. The hge-44 DNA sequence is divided into five areas represented by black, gray, white, hatched, and dark gray boxes. Clones that share similar sequences within these regions are shown by the presence of the same boxes. Lack of sequence similarity is represented by a single line. The hatched sequence area of the hge-44 gene is shared by all clones. Arrows indicate that inserts extend beyond the hge-44 sequence.

PCR and RNA-PCR. To confirm that hge-44 was present in the genome of aoHGE, the hge-44 gene was directly amplified from purified aoHGE DNA (Fig. 4, lane 5). Furthermore, to verify that hge-44 was expressed by aoHGE, total RNA from cultured aoHGE and from spleens of aoHGE-infected mice was prepared for RNA-PCR. The products of RNA-PCR were of the expected size of 1,279 nucleotides (Fig. 4, lanes 1 and 2), and the sequencing of the PCR products confirmed that hge-44 was transcribed both by aoHGE cultured in HL-60 cells and in vivo in aoHGE-infected mice.


View larger version (49K):
[in this window]
[in a new window]
  		FIG. 4.   RNA-PCR with total RNA from cultured aoHGE (lane 1) and from spleens from aoHGE-infected mice (lane 2), showing a 1,279-bp fragment. A product is not present in the controls (without reverse transcriptase) of cultured aoHGE RNA and spleen RNA (lanes 3 and 4, respectively), demonstrating that there was no DNA contamination. Total ehrlichial DNA was used as a template for the positive control (lane 5), and PCR buffer solution served as the negative control (lane 6). The molecular size marker (lane M) is the 1-kb ladder.

Expression of the hge-44 gene and immunoblotting. PCR was used to amplify hge-44 and subclone the gene into the pMX expression vector, such that it was in frame with the GT-coding sequence. Expression in E. coli produced a soluble GT-HGE-44 fusion protein of the expected size of 70 kDa on a Coomassie blue-stained gel (Fig. 5A, lane 4), while GT (control) was also expressed and yielded a band at 26 kDa (Fig. 5A, lane 3). E. coli lysates that expressed GT-HGE-44 or GT were then probed with serum from a patient with HGE in an IgG immunoblot (Fig. 5B). The patient serum reacted with GT-HGE-44 (Fig. 5B, lanes 2 and 4) but not with GT (Fig. 5B, lanes 1 and 3). The band at 70 kDa in E. coli containing the GT-HGE-44 expression plasmid demonstrates that low-level GT-HGE-44 synthesis occurs in the absence of IPTG (Fig. 5B, lane 2). Sera from normal healthy individuals did not recognize either protein (not shown). The GT-HGE-44 was then purified by using a glutathione column and used as a substrate in further immunoblotting studies.


View larger version (31K):
[in this window]
[in a new window]
  		FIG. 5.   Expression of GT-HGE-44. (A) Coomassie blue staining of E. coli lysates that expressed GT (lanes 1 and 3) and GT-HGE-44 (lanes 2 and 4). Lanes 1 and 2, no IPTG induction; lanes 3 and 4, with IPTG induction. (B) The E. coli lysates in panel A were probed with patient serum in an IgG immunoblot, showing reactivity to GT-HGE-44 but not to GT. The numbers on the left of each panel are molecular masses in kilodaltons.

A total of 26 human sera were then tested for IgM and IgG by immunoblotting with purified recombinant GT-HGE-44 as the substrate. Representative immunoblots are shown in Fig. 6. The sera included those from eight patients with HGE (15), five patients with E. chaffeensis infection, six patients with Lyme borreliosis, and seven normal healthy individuals. Sera from patients with E. chaffeensis or Borrelia burgdorferi infection had high-titer antibodies in E. chaffeensis IFA or B. burgdorferi enzyme-linked immunosorbent assay, respectively. All sera from HGE patients were obtained between 4 days and 6 weeks after the onset of symptoms, except for patient 2, whose serum was obtained 10 weeks after diagnosis. Six of the eight sera from patients with HGE had detectable IgM to recombinant HGE-44, and sera from all eight patients with HGE had discernible IgG. Faint bands below 70 kDa represent degradation products of the recombinant GT-HGE-44. The two HGE sera that had only IgG were obtained at 3 and 10 weeks, respectively. None of the sera from patients with E. chaffeensis or B. burgdorferi infection showed reactivity to recombinant HGE-44. In addition, normal healthy individuals did not have antibodies that bound GT-HGE-44. None of the sera that were tested bound recombinant GT (control) in immunoblotting (not shown).


View larger version (80K):
[in this window]
[in a new window]
  		FIG. 6.   IgM and IgG immunoblots of purified GT-HGE-44 probed with sera from patients with HGE (A), patients with E. chaffeensis infection (B), normal healthy volunteers (C), patients with Lyme disease (D), and aoHGE-infected mice (E) (IgG only).

Sera from two mice that were experimentally infected with aoHGE were also examined for antibodies (Fig. 6). Mice were infected by allowing aoHGE-infected ticks to engorge to repletion (25). Infection was documented by the identification of morulae in the murine neutrophils and cultivation of aoHGE in HL-60 cells from murine blood (25). Sera were obtained from the mice after 1 month of infection. Both animals had HGE-44 antibodies. As expected, serum from an uninfected mouse did not have antibodies that bound to GT-HGE-44 (not shown).

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In this study, we describe the cloning and characterization of hge-44, which codes for the immunogenic 44-kDa protein of aoHGE. hge-44 has similarity with the A. marginale msp-2 gene family. All sera of patients with HGE that were tested had antibodies recognizing the recombinant HGE-44 on immunoblots. This suggests that a serologic assay with recombinant HGE-44 as a substrate may facilitate laboratory diagnosis of HGE.

A. marginale is an arthropod-borne hemoparasite that induces severe anemia, abortion, and death in cattle (20). The close phylogenetic relationship between A. marginale and the E. phagocytophila group, including aoHGE, has been elucidated by using the 16S ribosomal DNA sequences (2, 6, 27). It is therefore not surprising that hge-44 has some similarity with the msp-2 gene family and that hge-44 may also be part of a group of closely related aoHGE genes. In A. marginale, the surface proteins encoded by the msp-2 genes are antigenic variants and elicit protective responses, suggesting a possible mechanism to evade the host immune response (9). It is conceivable that different isolates of aoHGE may express homologs of hge-44 and that aoHGE and A. marginale could employ similar strategies for survival within the host. Further studies need to investigate the role of HGE-44 with respect to potential protective immune responses. Already it has been demonstrated that sera from mice immunized with aoHGE-lysates (which contain high concentrations of antibodies that readily recognize HGE-44) afford protection against tick-borne aoHGE infection (25).

We have shown that a recombinant HGE-44 immunoblot can be used for the laboratory diagnosis of HGE. Eight HGE patient sera had either IgM or IgG antibodies that bound recombinant HGE-44, suggesting that an HGE-44-based assay is possible. However, larger numbers of HGE patients need to be tested in order to estimate the sensitivity of this assay. As expected, sera from healthy volunteers did not bind HGE-44. Moreover, none of the sera from patients with Lyme disease or E. chaffeensis infection showed reactivity to recombinant HGE-44, suggesting that HGE-44 antibodies are specific for HGE. Serologic IFA assays currently being used in the diagnosis of HGE contain E. equi- or aoHGE-infected cells as the substrate and consequently may occasionally yield false-positive results. The false-positive results in assays for aoHGE, E. chaffeensis, or B. burgdorferi infection are presumably due to cross-reactive antibodies that bind heat shock proteins and other antigens that are present in many bacteria (14, 16, 28, 29). An HGE-44-based assay could help to reduce these difficulties. Furthermore, the use of a recombinant HGE-44 as the substrate, rather than whole aoHGE organisms, eliminates the need to cultivate aoHGE and the possible effects that in vitro culture can cause with respect to pathogen stability, infectivity, and antigenic expression. Finally, recombinant HGE-44 can now be tested as a substrate for an automated enzyme-linked immunosorbent assay, which should reduce the cost and improve the interlaboratory and intralaboratory reliabilities of serodiagnostic assays for HGE.

HGE is a newly recognized tick-borne infection, and the role of the host immune response to this pathogen in disease remains to be elucidated. The gene, hge-44, encoding the major antigen of aoHGE is part of a gene family with similarity to A. marginale msp-2. The cloning of this gene represents a first step towards understanding the genetic structure of this pathogen.

    ACKNOWLEDGMENTS

This work was supported in part by the CDC (HR8/CCH113382-01) and NIH (AI-41440). J.W.I. is a Daland Fellow of the American Philosophical Society and is supported by a fellowship from the L.P. Markey Charitable Trust. E.F. is the recipient of a Burroughs Wellcome Clinical Scientist Award in Translational Research.

    FOOTNOTES

* Corresponding author. Mailing address: Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, 604 Laboratory of Clinical Investigation, 333 Cedar St., New Haven, CT 06520-4080. Phone: (203) 785-4080. Fax: (203) 785-7053. E-mail: erol.fikrig{at}yale.edu.

Editor:  J. R. McGhee

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Aguero-Rosenfeld, M. E., H. W. Horowitz, G. P. Wormser, D. F. McKenna, J. Nowakowski, J. Munoz, and J. S. Dumler. 1996. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann. Intern. Med. 125:905-908.
2. Anderson, B. E., J. E. Dawson, D. C. Jones, and K. H. Wilson. 1991. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 29:2838-2842[Abstract/Free Full Text].
3. Asanovich, K. M., J. S. Bakken, J. E. Madigan, M. Aguero-Rosenfeld, G. P. Wormser, and J. S. Dumler. 1997. Antigenic diversity of granulocytic ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J. Infect. Dis. 176:1029-1034[Medline].
4. Bakken, J. S., J. S. Dumler, S. M. Chen, M. R. Eckman, L. L. Van Etta, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging? JAMA 272:212-218[Abstract/Free Full Text].
5. Brouqui, P., J. S. Dumler, R. Lienhard, M. Brossard, and D. Raoult. 1995. Human granulocytic ehrlichiosis in Europe. Lancet 346:782-783[Medline].
6. Chen, S. M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytotropic ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595[Abstract/Free Full Text].
7. Chen, S. M., J. S. Dumler, H. M. Feng, and D. H. Walker. 1994. Identification of the antigenic constituents of Ehrlichia chaffeensis. Am. J. Trop. Med. Hyg. 50:52-58.
8. Dumler, J. S., K. M. Asanovich, J. S. Bakken, P. Richter, R. Kimsey, and J. E. Madigan. 1995. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia. J. Clin. Microbiol. 33:1098-1103[Abstract].
9. Eid, G., D. M. French, A. M. Lundgren, A. F. Barbet, T. F. McElwain, and G. H. Palmer. 1996. Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia. Infect. Immun. 64:836-841[Abstract].
10. Fingerle, V., G. L. Goodman, R. C. Johnson, T. J. Kurtti, U. G. Munderloh, and B. Wilske. 1997. Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J. Clin. Microbiol. 35:3244-3247[Abstract].
11. Goodman, J. L., C. Nelson, B. Vitale, J. E. Madigan, J. S. Dumler, T. J. Kurtti, and U. G. Munderloh. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334:209-215[Abstract/Free Full Text].
12. Hanson, B. A., C. L. Wisseman, A. Waddell, and D. J. Silverman. 1981. Some characteristics of heavy and light bands of Rickettsia prowazekii on Renografin gradients. Infect. Immun. 34:596-604[Abstract/Free Full Text].
13. Hardalo, C. J., V. Quagliarello, and J. S. Dumler. 1995. Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin. Infect. Dis. 21:910-914[Medline].
14. IJdo, J. W., Y. Zhang, M. L. Anderson, D. Goldberg, and E. Fikrig. 1998. Heat shock protein 70 of the agent of human granulocytic ehrlichiosis binds to Borrelia burgdorferi antibodies. Clin. Diagn. Lab. Med. 5:118-129.
15. IJdo, J. W., Y. Zhang, E. Hodzic, L. A. Magnarelli, M. L. Wilson, S. R. Telford, S. W. Barthold, and E. Fikrig. 1997. The early humoral response in human granulocytic ehrlichiosis. J. Infect. Dis. 176:687-692[Medline].
16. Kolbert, C. P., E. S. Bruinsma, A. S. Abdulkarim, E. K. Hofmeister, R. B. Tompkins, S. R. Telford, P. D. Mitchell, J. Adams-Stich, and D. H. Persing. 1997. Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J. Clin. Microbiol. 35:1172-1178[Abstract].
17. Magnarelli, L. A., J. S. Dumler, J. F. Anderson, R. C. Johnson, and E. Fikrig. 1995. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J. Clin. Microbiol. 33:3054-3057[Abstract].
18. Nicholson, W. L., J. A. Comer, J. W. Sumner, C. Gingrichbaker, R. T. Coughlin, L. A. Magnarelli, J. G. Olson, and J. E. Childs. 1997. An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J. Clin. Microbiol. 35:1510-1516[Abstract].
19. Nyindo, M., I. Kakoma, and R. Hansen. 1991. Antigenic analysis of four species of the genus Ehrlichia by use of protein immunoblot. Am. J. Vet. Res. 52:1225-1230[Medline].
20. Palmer, G. H., G. Eid, A. F. Barbet, T. C. McGuire, and T. F. McElwain. 1994. The immunoprotective Anaplasma marginale major surface protein 2 is encoded by a polymorphic multigene family. Infect. Immun. 62:3808-3816[Abstract/Free Full Text].
21. Pancholi, P., C. P. Kolbert, P. D. Mitchell, K. D. Reed, Jr., J. S. Dumler, J. S. Bakken, S. R. Telford III, and D. H. Persing. 1995. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J. Infect. Dis. 172:1007-1012[Medline].
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 9.19. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
23. Sears, J. E., E. Fikrig, T. Y. Nakagawa, K. Deponte, N. Marcantonio, F. S. Kantor, and R. A. Flavell. 1991. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J. Immunol. 147:1995-2000[Abstract].
24. Sumpton, K. J., D. J. M. Wright, S. J. Cutler, and B. A. S. Dale. 1995. Human granulocytic ehrlichiosis in the UK. Lancet 346:1487-1488[Medline].
25. Sun, W., J. W. IJdo, S. R. Telford, E. Hodzic, Y. Zhang, S. W. Barthold, and E. Fikrig. 1997. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Invest. 100:3014-3018[Medline].
26. Walker, D. H., and J. S. Dumler. 1996. Emergence of the ehrlichiosis as human health problems. J. Emerg. Infect. Dis. 2:18-29. [Medline]
27. Weisburg, W. G., M. E. Dobson, J. E. Samuel, G. A. Dasch, L. P. Mallavia, O. Baca, L. Mandelco, J. E. Sechrest, E. Weiss, and C. R. Woese. 1989. Phylogenetic diversity of the rickettsiae. J. Bacteriol. 171:4202-4206[Abstract/Free Full Text].
28. Wong, S. J., G. S. Brady, and J. S. Dumler. 1997. Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J. Clin. Microbiol. 35:2198-2205[Abstract].
29. Wormser, G. P., H. W. Horowitz, J. Nowakowski, D. Mckenna, J. S. Dumler, S. Varde, I. Schwartz, C. Carbonaro, and M. Aguero-Rosenfeld. 1997. Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am. J. Clin. Pathol. 107:142-147[Medline].
30. Zhi, N., Y. Rikihisa, H. Y. Kim, G. P. Wormser, and H. W. Horowitz. 1997. Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J. Clin. Microbiol. 35:2606-2611[Abstract].

Infect Immun, July 1998, p. 3264-3269, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Troese, M. J., Sarkar, M., Galloway, N. L., Thomas, R. J., Kearns, S. A., Reneer, D. V., Yang, T., Carlyon, J. A. (2009). Differential Expression and Glycosylation of Anaplasma phagocytophilum Major Surface Protein 2 Paralogs during Cultivation in Sialyl Lewis x-Deficient Host Cells. Infect. Immun. 77: 1746-1756 [Abstract] [Full Text]  
  • Sarkar, M., Troese, M. J., Kearns, S. A., Yang, T., Reneer, D. V., Carlyon, J. A. (2008). Anaplasma phagocytophilum MSP2(P44)-18 Predominates and Is Modified into Multiple Isoforms in Human Myeloid Cells. Infect. Immun. 76: 2090-2098 [Abstract] [Full Text]  
  • Zhang, C., Xiong, Q., Kikuchi, T., Rikihisa, Y. (2008). Identification of 19 Polymorphic Major Outer Membrane Protein Genes and Their Immunogenic Peptides in Ehrlichia ewingii for Use in a Serodiagnostic Assay. CVI 15: 402-411 [Abstract] [Full Text]  
  • Pedra, J. H. F., Mattner, J., Tao, J., Kerfoot, S. M., Davis, R. J., Flavell, R. A., Askenase, P. W., Yin, Z., Fikrig, E. (2008). c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection. Infect. Immun. 76: 308-316 [Abstract] [Full Text]  
  • Wang, X., Cheng, Z., Zhang, C., Kikuchi, T., Rikihisa, Y. (2007). Anaplasma phagocytophilum p44 mRNA Expression Is Differentially Regulated in Mammalian and Tick Host Cells: Involvement of the DNA Binding Protein ApxR. J. Bacteriol. 189: 8651-8659 [Abstract] [Full Text]  
  • Barbet, A. F., Lundgren, A. M., Alleman, A. R., Stuen, S., Bjoersdorff, A., Brown, R. N., Drazenovich, N. L., Foley, J. E. (2006). Structure of the Expression Site Reveals Global Diversity in MSP2 (P44) Variants in Anaplasma phagocytophilum. Infect. Immun. 74: 6429-6437 [Abstract] [Full Text]  
  • Lopez, J. E., Siems, W. F., Palmer, G. H., Brayton, K. A., McGuire, T. C., Norimine, J., Brown, W. C. (2005). Identification of Novel Antigenic Proteins in a Complex Anaplasma marginale Outer Membrane Immunogen by Mass Spectrometry and Genomic Mapping. Infect. Immun. 73: 8109-8118 [Abstract] [Full Text]  
  • Abbott, J. R., Palmer, G. H., Kegerreis, K. A., Hetrick, P. F., Howard, C. J., Hope, J. C., Brown, W. C. (2005). Rapid and Long-Term Disappearance of CD4+ T Lymphocyte Responses Specific for Anaplasma Marginale Major Surface Protein-2 (MSP2) in MSP2 Vaccinates following Challenge with Live A. marginale. J. Immunol. 174: 6702-6715 [Abstract] [Full Text]  
  • Thomas, V., Samanta, S., Wu, C., Berliner, N., Fikrig, E. (2005). Anaplasma phagocytophilum Modulates gp91phox Gene Expression through Altered Interferon Regulatory Factor 1 and PU.1 Levels and Binding of CCAAT Displacement Protein. Infect. Immun. 73: 208-218 [Abstract] [Full Text]  
  • Abbott, J. R., Palmer, G. H., Howard, C. J., Hope, J. C., Brown, W. C. (2004). Anaplasma marginale Major Surface Protein 2 CD4+-T-Cell Epitopes Are Evenly Distributed in Conserved and Hypervariable Regions (HVR), Whereas Linear B-Cell Epitopes Are Predominantly Located in the HVR. Infect. Immun. 72: 7360-7366 [Abstract] [Full Text]  
  • Courtney, J. W., Kostelnik, L. M., Zeidner, N. S., Massung, R. F. (2004). Multiplex Real-Time PCR for Detection of Anaplasma phagocytophilum and Borrelia burgdorferi. J. Clin. Microbiol. 42: 3164-3168 [Abstract] [Full Text]  
  • Carlyon, J. A., Akkoyunlu, M., Xia, L., Yago, T., Wang, T., Cummings, R. D., McEver, R. P., Fikrig, E. (2003). Murine neutrophils require {alpha}1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102: 3387-3395 [Abstract] [Full Text]  
  • Munderloh, U. G., Tate, C. M., Lynch, M. J., Howerth, E. W., Kurtti, T. J., Davidson, W. R. (2003). Isolation of an Anaplasma sp. Organism from White-Tailed Deer by Tick Cell Culture. J. Clin. Microbiol. 41: 4328-4335 [Abstract] [Full Text]  
  • Stuen, S., Bergstrom, K., Petrovec, M., Van de Pol, I., Schouls, L. M. (2003). Differences in Clinical Manifestations and Hematological and Serological Responses after Experimental Infection with Genetic Variants of Anaplasma phagocytophilum in Sheep. CVI 10: 692-695 [Abstract] [Full Text]  
  • Park, J., Choi, K. S., Dumler, J. S. (2003). Major Surface Protein 2 of Anaplasma phagocytophilum Facilitates Adherence to Granulocytes. Infect. Immun. 71: 4018-4025 [Abstract] [Full Text]  
  • Barbet, A. F., Meeus, P. F. M., Belanger, M., Bowie, M. V., Yi, J., Lundgren, A. M., Alleman, A. R., Wong, S. J., Chu, F. K., Munderloh, U. G., Jauron, S. D. (2003). Expression of Multiple Outer Membrane Protein Sequence Variants from a Single Genomic Locus of Anaplasma phagocytophilum. Infect. Immun. 71: 1706-1718 [Abstract] [Full Text]  
  • Brown, W. C., Brayton, K. A., Styer, C. M., Palmer, G. H. (2003). The Hypervariable Region of Anaplasma marginale Major Surface Protein 2 (MSP2) Contains Multiple Immunodominant CD4+ T Lymphocyte Epitopes That Elicit Variant-Specific Proliferative and IFN-{gamma} Responses in MSP2 Vaccinates. J. Immunol. 170: 3790-3798 [Abstract] [Full Text]  
  • Massung, R. F., Slater, K. G. (2003). Comparison of PCR Assays for Detection of the Agent of Human Granulocytic Ehrlichiosis, Anaplasma phagocytophilum. J. Clin. Microbiol. 41: 717-722 [Abstract] [Full Text]  
  • IJdo, J. W., Wu, C., Telford III, S. R., Fikrig, E. (2002). Differential Expression of the p44 Gene Family in the Agent of Human Granulocytic Ehrlichiosis. Infect. Immun. 70: 5295-5298 [Abstract] [Full Text]  
  • Stuen, S., Van De Pol, I., Bergstrom, K., Schouls, L. M. (2002). Identification of Anaplasma phagocytophila (Formerly Ehrlichia phagocytophila) Variants in Blood from Sheep in Norway. J. Clin. Microbiol. 40: 3192-3197 [Abstract] [Full Text]  
  • Lin, Q., Zhi, N., Ohashi, N., Horowitz, H. W., Aguero-Rosenfeld, M. E., Raffalli, J., Wormser, G. P., Rikihisa, Y. (2002). Analysis of Sequences and Loci of p44 Homologs Expressed by Anaplasma phagocytophila in Acutely Infected Patients. J. Clin. Microbiol. 40: 2981-2988 [Abstract] [Full Text]  
  • MAGNARELLI, L. A., IJDO, J. W., SHERMAN, B. A., BUSHMICH, S. L., LEVY, S. A., FIKRIG, E. (2002). Antibodies to granulocytic ehrlichiae in cattle from Connecticut. J Med Microbiol 51: 326-331 [Abstract] [Full Text]  
  • Caspersen, K., Park, J.-H., Patil, S., Dumler, J. S. (2002). Genetic Variability and Stability of Anaplasma phagocytophila msp2 (p44). Infect. Immun. 70: 1230-1234 [Abstract] [Full Text]  
  • Shkap, V., Molad, T., Brayton, K. A., Brown, W. C., Palmer, G. H. (2002). Expression of Major Surface Protein 2 Variants with Conserved T-Cell Epitopes in Anaplasma centrale Vaccinates. Infect. Immun. 70: 642-648 [Abstract] [Full Text]  
  • Akkoyunlu, M., Malawista, S. E., Anguita, J., Fikrig, E. (2001). Exploitation of Interleukin-8-Induced Neutrophil Chemotaxis by the Agent of Human Granulocytic Ehrlichiosis. Infect. Immun. 69: 5577-5588 [Abstract] [Full Text]  
  • Carter, S. E., Ravyn, M. D., Xu, Y., Johnson, R. C. (2001). Molecular Typing of the Etiologic Agent of Human Granulocytic Ehrlichiosis. J. Clin. Microbiol. 39: 3398-3401 [Abstract] [Full Text]  
  • Lodes, M. J., Mohamath, R., Reynolds, L. D., McNeill, P., Kolbert, C. P., Bruinsma, E. S., Benson, D. R., Hofmeister, E., Reed, S. G., Houghton, R. L., Persing, D. H. (2001). Serodiagnosis of Human Granulocytic Ehrlichiosis by Using Novel Combinations of Immunoreactive Recombinant Proteins. J. Clin. Microbiol. 39: 2466-2476 [Abstract] [Full Text]  
  • Thomas, V., Anguita, J., Barthold, S. W., Fikrig, E. (2001). Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis. Infect. Immun. 69: 3359-3371 [Abstract] [Full Text]  
  • Shu-yi Li, J., Yager, E., Reilly, M., Freeman, C., Reddy, G. R., Reilly, A. A., Chu, F. K., Winslow, G. M. (2001). Outer Membrane Protein-Specific Monoclonal Antibodies Protect SCID Mice from Fatal Infection by the Obligate Intracellular Bacterial Pathogen Ehrlichia chaffeensis. J. Immunol. 166: 1855-1862 [Abstract] [Full Text]  
  • Brown, W. C., McGuire, T. C., Zhu, D., Lewin, H. A., Sosnow, J., Palmer, G. H. (2001). Highly Conserved Regions of the Immunodominant Major Surface Protein 2 of the Genogroup II Ehrlichial Pathogen Anaplasma marginale Are Rich in Naturally Derived CD4+ T Lymphocyte Epitopes that Elicit Strong Recall Responses. J. Immunol. 166: 1114-1124 [Abstract] [Full Text]  
  • Ravyn, M. D., Kodner, C. B., Carter, S. E., Jarnefeld, J. L., Johnson, R. C. (2001). Isolation of the Etiologic Agent of Human Granulocytic Ehrlichiosis from the White-Footed Mouse (Peromyscus leucopus). J. Clin. Microbiol. 39: 335-338 [Abstract] [Full Text]  
  • Barbet, A. F., Lundgren, A., Yi, J., Rurangirwa, F. R., Palmer, G. H. (2000). Antigenic Variation of Anaplasma marginale by Expression of MSP2 Mosaics. Infect. Immun. 68: 6133-6138 [Abstract] [Full Text]  
  • Caturegli, P., Asanovich, K. M., Walls, J. J., Bakken, J. S., Madigan, J. E., Popov, V. L., Dumler, J. S. (2000). ankA: an Ehrlichia phagocytophila Group Gene Encoding a Cytoplasmic Protein Antigen with Ankyrin Repeats. Infect. Immun. 68: 5277-5283 [Abstract] [Full Text]  
  • Akkoyunlu, M., Fikrig, E. (2000). Gamma Interferon Dominates the Murine Cytokine Response to the Agent of Human Granulocytic Ehrlichiosis and Helps To Control the Degree of Early Rickettsemia. Infect. Immun. 68: 1827-1833 [Abstract] [Full Text]  
  • Chang, Y.-F., McDonough, S. P., Chang, C.-F., Shin, K.-S., Yen, W., Divers, T. (2000). Human Granulocytic Ehrlichiosis Agent Infection in a Pony Vaccinated with a Borrelia burgdorferi Recombinant OspA Vaccine and Challenged by Exposure to Naturally Infected Ticks. CVI 7: 68-71 [Abstract] [Full Text]  
  • Tuo, W., Palmer, G. H., McGuire, T. C., Zhu, D., Brown, W. C. (2000). Interleukin-12 as an Adjuvant Promotes Immunoglobulin G and Type 1 Cytokine Recall Responses to Major Surface Protein 2 of the Ehrlichial Pathogen Anaplasma marginale. Infect. Immun. 68: 270-280 [Abstract] [Full Text]  
  • French, D. M., Brown, W. C., Palmer, G. H. (1999). Emergence of Anaplasma marginale Antigenic Variants during Persistent Rickettsemia. Infect. Immun. 67: 5834-5840 [Abstract] [Full Text]  
  • Ijdo, J. W., Wu, C., Magnarelli, L. A., Fikrig, E. (1999). Serodiagnosis of Human Granulocytic Ehrlichiosis by a Recombinant HGE-44-Based Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol. 37: 3540-3544 [Abstract] [Full Text]  
  • Stafford, K. C. III, Massung, R. F., Magnarelli, L. A., Ijdo, J. W., Anderson, J. F. (1999). Infection with Agents of Human Granulocytic Ehrlichiosis, Lyme Disease, and Babesiosis in Wild White-Footed Mice (Peromyscus leucopus) in Connecticut. J. Clin. Microbiol. 37: 2887-2892 [Abstract] [Full Text]  
  • Walls, J. J., Aguero-Rosenfeld, M., Bakken, J. S., Goodman, J. L., Hossain, D., Johnson, R. C., Dumler, J. S. (1999). Inter- and Intralaboratory Comparison of Ehrlichia equi and Human Granulocytic Ehrlichiosis (HGE) Agent Strains for Serodiagnosis of HGE by the Immunofluorescent-Antibody Test. J. Clin. Microbiol. 37: 2968-2973 [Abstract] [Full Text]  
  • Zhi, N., Ohashi, N., Rikihisa, Y. (1999). Multiple p44 Genes Encoding Major Outer Membrane Proteins Are Expressed in the Human Granulocytic Ehrlichiosis Agent. J. Biol. Chem. 274: 17828-17836 [Abstract] [Full Text]  
  • van Dobbenburgh, A., van Dam, A. P., Fikrig, E. (1999). Human Granulocytic Ehrlichiosis in Western Europe. NEJM 340: 1214-1216 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ijdo, J. W.
Right arrow Articles by Fikrig, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ijdo, J. W.
Right arrow Articles by Fikrig, E.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»